LINDSAY CROCKER: Open Payments
NPI 1730488669 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 60 payments from 13 companies in 2025. Trend: 2023 $760 · 2024 $846 · 2025 $1,096
Food & beverage: $1,051Education: $45
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $241 |
| ABBVIE INC. | 13 | $177 |
| Lilly USA, LLC | 9 | $148 |
| Astellas Pharma US Inc | 7 | $139 |
| Novo Nordisk Inc | 7 | $129 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| Exact Sciences Corporation | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Amgen Inc. | 2 | $30 |
Products named: FARXIGA, Veozah, JARDIANCE, QULIPTA, MOUNJARO, VRAYLAR, AIRSUPRA, Wegovy.
Industry payments across TN — which companies pay providers there.
